| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Pediatric Neurology Unit (Drs. Shapira, Edwardson, and Matoth), Hadassah University Hospital, Jerusalem; Wolfson Medical Center (Dr. Sadeh), Holon, Israel; New Hyde Park (Dr. Bergtraum), New York, NY; and Department of Neurology and Neuromuscular Research Laboratory (Drs. Tsujino, Ohno, Shen, Brengman, and Engel), Mayo Clinic, Rochester, MN.
Address correspondence and reprint requests to Dr. Andrew G. Engel, Department of Neurology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905; e-mail: age{at}mayo.edu
Objective: To determine the molecular basis and consequences of endplate (EP) acetylcholinesterase (AChE) deficiency.
Background: The EP species AChE is an asymmetric enzyme consisting of a tail subunit composed of three collagenic strands (ColQ), each attached to a tetramer of catalytic subunits. The tail subunit is essential for insertion of AChE into the synaptic basal lamina. Human EP AChE deficiency is caused by mutations in COLQ. The authors report three novel COLQ mutations in eight kinships.
Methods: Immunocytochemistry, electron microscopy, microelectrode recordings, mutation analysis, and expression studies in COS cells were employed.
Results: Two mutations (275insC and Q211X) were heterozygous in one patient. EP studies in this patient revealed no EP AChE, small nerve terminals, reduced presynaptic membrane length, as well as abnormally low-evoked quantal release. The third mutation (G240X) was homozygous in six Palestinian Arab families of the same tribe and in an Iraqi Jewish patient. Expression studies of the three mutations in COS cells indicate that each abrogates formation of insertion competent asymmetric AChE. Although the three mutations have identical predicted consequences at the EP, their phenotypic expressivity varies as regards age at onset, rate of progression, and severity of symptoms.
Conclusions: 1) After mutations in the AChR 
subunit, mutations in COLQ are emerging as second most common cause of congenital myasthenic syndromes. 2) A founder effect is likely for G240X in the Palestinian Arab families. 3) That mutations predicting total absence of AChE from the EP have variable phenotypic expressivity suggests that modifying genes or environmental factors can partially compensate for EP AChE deficiency.
This article has been cited by other articles:
|
|
 |
|
  P. Richard, K. Gaudon, H. Haddad, A. B. Ammar, E. Genin, S. Bauche, M. Paturneau-Jouas, J. S. Muller, H. Lochmuller, D. Grid, et al. The CHRNE 1293insG founder mutation is a frequent cause of congenital myasthenia in North Africa Neurology, December 9, 2008; 71(24): 1967 - 1972. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Mihaylova, J. S. Muller, J. J. Vilchez, M. A. Salih, M. M. Kabiraj, A. D'Amico, E. Bertini, J. Wolfle, F. Schreiner, G. Kurlemann, et al. Clinical and molecular genetic findings in COLQ-mutant congenital myasthenic syndromes Brain, March 1, 2008; 131(3): 747 - 759. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Bestue-Cardiel, A. S. de Cabezon-Alvarez, J. L. Capablo-Liesa, J. Lopez-Pison, J. L. Pena-Segura, J. Martin-Martinez, and A. G. Engel Congenital endplate acetylcholinesterase deficiency responsive to ephedrine Neurology, July 12, 2005; 65(1): 144 - 146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Muller, G. Mildner, W. Muller-Felber, U. Schara, K. Krampfl, B. Petersen, S. Petrova, R. Stucka, W. Mortier, J. Bufler, et al. Rapsyn N88K is a frequent cause of congenital myasthenic syndromes in European patients Neurology, June 10, 2003; 60(11): 1805 - 1810. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Sanes The Basement Membrane/Basal Lamina of Skeletal Muscle J. Biol. Chem., April 4, 2003; 278(15): 12601 - 12604. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
